STEPHEN DAVIS

Profile

First Name

: STEPHEN

Middle Name

:

Last Name

: DAVIS

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, PROMOTER
EXECUTIVE OFFICER, PROMOTER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2025-02-28 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-24 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-05 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-08-26 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-03-10 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-03-14 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-19 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-26 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-25 
D/A
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-29 
D/A
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-03 
D
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-15 
D/A
OTHER INVESTMENT FUND 
 
 
 
2022-08-15 
D/A
OTHER INVESTMENT FUND 
 
 
 
2022-08-15 
D/A
OTHER INVESTMENT FUND 
 
 
 
2022-08-15 
D/A
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-21 
D
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-21 
D/A
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-21 
D
OTHER INVESTMENT FUND 
 
 
 
2022-08-15 
D
OTHER INVESTMENT FUND 
 
 
 
2022-08-15 
D
OTHER INVESTMENT FUND 
 
 
 
2022-08-15 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-01 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-30 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-15 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-22 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2020-12-21 
D
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-02 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-22 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-22 
D
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-27 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-23 
D
OTHER TECHNOLOGY 
 
$25,000,001 - $100,000,000 
Equity 
2015-07-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-05-14 
D
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-15 
D
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-05-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-05-14 
D/A
BUSINESS SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-07 
D
BUSINESS SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-07 
D
BUSINESS SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2009-03-18 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-13 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-22 
D
BUSINESS SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2009-03-18 
D
BUSINESS SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-15 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-05